LD
GEHC icon

Lipe & Dalton’s GE HealthCare GEHC Stock Holding History

Lipe & Dalton’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,530
Closed -$678K – 97
2026
Q1 		$678K Buy
9,530
+1
+0% +$79 0.35% 49
2025
Q4 		$782K Sell
9,529
-197
-2% -$15.3K 0.39% 48
2025
Q3 		$730K Sell
9,726
-200
-2% -$14.9K 0.36% 56
2025
Q2 		$735K Sell
9,926
-399
-4% -$27.8K 0.4% 51
2025
Q1 		$833K Sell
10,325
-830
-7% -$71.3K 0.47% 51
2024
Q4 		$872K Sell
11,155
-200
-2% -$17K 0.46% 52
2024
Q3 		$1.07M Sell
11,355
-50
-0.4% -$4.2K 0.54% 53
2024
Q2 		$889K Buy
11,405
+41
+0.4% +$3.34K 0.48% 56
2024
Q1 		$1.03M Sell
11,364
-549
-5% -$45.7K 0.53% 51
2023
Q4 		$921K Sell
11,913
-200
-2% -$14K 0.5% 52
2023
Q3 		$824K Buy
12,113
+308
+3% +$22.4K 0.5% 51
2023
Q2 		$959K Hold
11,805
– – 0.55% 51
2023
Q1 		$968K Buy
+11,805
New +$843K 0.55% 50

Other funds holding GEHC

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return

Lipe & Dalton's GEHC Position: Q2 2026 in Review

Lipe & Dalton sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 9,530 shares — an estimated $678K sold.

Lipe & Dalton first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $1.07M in Q3 2024. 502 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Lipe & Dalton reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Lipe & Dalton sold 9,530 GE HealthCare shares in Q2 2026, an estimated $678K.
  • Lipe & Dalton first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Lipe & Dalton's GE HealthCare position peaked at $1.07M in Q3 2024.
  • 502 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.